Medical Care

Global Sexually Transmitted Diseases Diagnostics Market Research Report 2026

This report delivers a comprehensive overview of the global Sexually Transmitted Diseases Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sexually Transmitted Diseases Diagnostics. The Sexually Transmitted Diseases Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sexually Transmitted Diseases Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sexually Transmitted Diseases Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
Thermo Fisher Scientific
CERTEST BIOTEC
OPERON
Roche
Bio-Rad laboratories
Qaigen
Diasorin SPA
MedMira
Hologic
Cepheid
BioMeriuex
Segment by Type
Cultural and Isolated Organisms
Molecular Test
Immunology Assay
Other
Segment by Application
Gonorrhea
Syphilis
Chlamydia
Herpes Simplex Virus
Human Papillomavirus
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sexually Transmitted Diseases Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cultural and Isolated Organisms
1.2.3 Molecular Test
1.2.4 Immunology Assay
1.2.5 Other
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Gonorrhea
1.3.3 Syphilis
1.3.4 Chlamydia
1.3.5 Herpes Simplex Virus
1.3.6 Human Papillomavirus
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases Diagnostics Market Perspective (2021–2032)
2.2 Global Sexually Transmitted Diseases Diagnostics Growth Trends by Region
2.2.1 Global Sexually Transmitted Diseases Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Sexually Transmitted Diseases Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Sexually Transmitted Diseases Diagnostics Market Dynamics
2.3.1 Sexually Transmitted Diseases Diagnostics Industry Trends
2.3.2 Sexually Transmitted Diseases Diagnostics Market Drivers
2.3.3 Sexually Transmitted Diseases Diagnostics Market Challenges
2.3.4 Sexually Transmitted Diseases Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases Diagnostics Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Sexually Transmitted Diseases Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Sexually Transmitted Diseases Diagnostics Revenue
3.4 Global Sexually Transmitted Diseases Diagnostics Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Diagnostics Revenue in 2025
3.5 Global Key Players of Sexually Transmitted Diseases Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Sexually Transmitted Diseases Diagnostics, Products and Applications
3.7 Global Key Players of Sexually Transmitted Diseases Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases Diagnostics Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Type (2027–2032)
5 Sexually Transmitted Diseases Diagnostics Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)
6.2 North America Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)
6.4 North America Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)
7.2 Europe Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)
7.4 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)
9.2 Latin America Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sexually Transmitted Diseases Diagnostics Introduction
11.1.4 Abbott Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 CERTEST BIOTEC
11.3.1 CERTEST BIOTEC Company Details
11.3.2 CERTEST BIOTEC Business Overview
11.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Introduction
11.3.4 CERTEST BIOTEC Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.3.5 CERTEST BIOTEC Recent Development
11.4 OPERON
11.4.1 OPERON Company Details
11.4.2 OPERON Business Overview
11.4.3 OPERON Sexually Transmitted Diseases Diagnostics Introduction
11.4.4 OPERON Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.4.5 OPERON Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Sexually Transmitted Diseases Diagnostics Introduction
11.5.4 Roche Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.5.5 Roche Recent Development
11.6 Bio-Rad laboratories
11.6.1 Bio-Rad laboratories Company Details
11.6.2 Bio-Rad laboratories Business Overview
11.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Introduction
11.6.4 Bio-Rad laboratories Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.6.5 Bio-Rad laboratories Recent Development
11.7 Qaigen
11.7.1 Qaigen Company Details
11.7.2 Qaigen Business Overview
11.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Introduction
11.7.4 Qaigen Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.7.5 Qaigen Recent Development
11.8 Diasorin SPA
11.8.1 Diasorin SPA Company Details
11.8.2 Diasorin SPA Business Overview
11.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Introduction
11.8.4 Diasorin SPA Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.8.5 Diasorin SPA Recent Development
11.9 MedMira
11.9.1 MedMira Company Details
11.9.2 MedMira Business Overview
11.9.3 MedMira Sexually Transmitted Diseases Diagnostics Introduction
11.9.4 MedMira Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.9.5 MedMira Recent Development
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic Sexually Transmitted Diseases Diagnostics Introduction
11.10.4 Hologic Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.10.5 Hologic Recent Development
11.11 Cepheid
11.11.1 Cepheid Company Details
11.11.2 Cepheid Business Overview
11.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Introduction
11.11.4 Cepheid Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.11.5 Cepheid Recent Development
11.12 BioMeriuex
11.12.1 BioMeriuex Company Details
11.12.2 BioMeriuex Business Overview
11.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Introduction
11.12.4 BioMeriuex Revenue in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
11.12.5 BioMeriuex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cultural and Isolated Organisms
Table 3. Key Players of Molecular Test
Table 4. Key Players of Immunology Assay
Table 5. Key Players of Other
Table 6. Global Sexually Transmitted Diseases Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Sexually Transmitted Diseases Diagnostics Market Share by Region (2021–2026)
Table 10. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Sexually Transmitted Diseases Diagnostics Market Share by Region (2027–2032)
Table 12. Sexually Transmitted Diseases Diagnostics Market Trends
Table 13. Sexually Transmitted Diseases Diagnostics Market Drivers
Table 14. Sexually Transmitted Diseases Diagnostics Market Challenges
Table 15. Sexually Transmitted Diseases Diagnostics Market Restraints
Table 16. Global Sexually Transmitted Diseases Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Sexually Transmitted Diseases Diagnostics Market Share by Players (2021–2026)
Table 18. Global Top Sexually Transmitted Diseases Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sexually Transmitted Diseases Diagnostics Revenue, 2025
Table 19. Ranking of Global Top Sexually Transmitted Diseases Diagnostics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Diseases Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Sexually Transmitted Diseases Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Sexually Transmitted Diseases Diagnostics, Products and Applications
Table 23. Global Key Players of Sexually Transmitted Diseases Diagnostics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Sexually Transmitted Diseases Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Type (2021–2026)
Table 27. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Type (2027–2032)
Table 29. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Application (2021–2026)
Table 31. Global Sexually Transmitted Diseases Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Application (2027–2032)
Table 33. North America Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Sexually Transmitted Diseases Diagnostics Product
Table 51. Abbott Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 52. Abbott Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product
Table 56. Thermo Fisher Scientific Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 57. Thermo Fisher Scientific Recent Development
Table 58. CERTEST BIOTEC Company Details
Table 59. CERTEST BIOTEC Business Overview
Table 60. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product
Table 61. CERTEST BIOTEC Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 62. CERTEST BIOTEC Recent Development
Table 63. OPERON Company Details
Table 64. OPERON Business Overview
Table 65. OPERON Sexually Transmitted Diseases Diagnostics Product
Table 66. OPERON Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 67. OPERON Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Sexually Transmitted Diseases Diagnostics Product
Table 71. Roche Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 72. Roche Recent Development
Table 73. Bio-Rad laboratories Company Details
Table 74. Bio-Rad laboratories Business Overview
Table 75. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product
Table 76. Bio-Rad laboratories Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 77. Bio-Rad laboratories Recent Development
Table 78. Qaigen Company Details
Table 79. Qaigen Business Overview
Table 80. Qaigen Sexually Transmitted Diseases Diagnostics Product
Table 81. Qaigen Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 82. Qaigen Recent Development
Table 83. Diasorin SPA Company Details
Table 84. Diasorin SPA Business Overview
Table 85. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product
Table 86. Diasorin SPA Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 87. Diasorin SPA Recent Development
Table 88. MedMira Company Details
Table 89. MedMira Business Overview
Table 90. MedMira Sexually Transmitted Diseases Diagnostics Product
Table 91. MedMira Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 92. MedMira Recent Development
Table 93. Hologic Company Details
Table 94. Hologic Business Overview
Table 95. Hologic Sexually Transmitted Diseases Diagnostics Product
Table 96. Hologic Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 97. Hologic Recent Development
Table 98. Cepheid Company Details
Table 99. Cepheid Business Overview
Table 100. Cepheid Sexually Transmitted Diseases Diagnostics Product
Table 101. Cepheid Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 102. Cepheid Recent Development
Table 103. BioMeriuex Company Details
Table 104. BioMeriuex Business Overview
Table 105. BioMeriuex Sexually Transmitted Diseases Diagnostics Product
Table 106. BioMeriuex Revenue in Sexually Transmitted Diseases Diagnostics Business (US$ Million), 2021–2026
Table 107. BioMeriuex Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report


List of Figures
Figure 1. Sexually Transmitted Diseases Diagnostics Picture
Figure 2. Global Sexually Transmitted Diseases Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Sexually Transmitted Diseases Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Cultural and Isolated Organisms Features
Figure 5. Molecular Test Features
Figure 6. Immunology Assay Features
Figure 7. Other Features
Figure 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Sexually Transmitted Diseases Diagnostics Market Share by Application: 2025 vs 2032
Figure 10. Gonorrhea Case Studies
Figure 11. Syphilis Case Studies
Figure 12. Chlamydia Case Studies
Figure 13. Herpes Simplex Virus Case Studies
Figure 14. Human Papillomavirus Case Studies
Figure 15. Others Case Studies
Figure 16. Sexually Transmitted Diseases Diagnostics Report Years Considered
Figure 17. Global Sexually Transmitted Diseases Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Sexually Transmitted Diseases Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Sexually Transmitted Diseases Diagnostics Market Share by Region: 2025 vs 2032
Figure 20. Global Sexually Transmitted Diseases Diagnostics Market Share by Players in 2025
Figure 21. Global Sexually Transmitted Diseases Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases Diagnostics Revenue in 2025
Figure 23. North America Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)
Figure 25. United States Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)
Figure 29. Germany Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market Share by Region (2021–2032)
Figure 37. China Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)
Figure 45. Mexico Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Share by Country (2021–2032)
Figure 49. Israel Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Sexually Transmitted Diseases Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 54. CERTEST BIOTEC Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 55. OPERON Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 56. Roche Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 57. Bio-Rad laboratories Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 58. Qaigen Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 59. Diasorin SPA Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 60. MedMira Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 61. Hologic Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 62. Cepheid Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 63. BioMeriuex Revenue Growth Rate in Sexually Transmitted Diseases Diagnostics Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies